References
- Fanos V, Benini D, Verlato G, et al. Efficacy and renal tolerability of ibuprofen vs. indomethacin in preterm infants with patent ductus arteriosus. Fundam Clin Pharmacol 2005;19:187–93
- Hamrick SE, Hansmann G. Patent ductus arteriosus of the preterm infant. Pediatrics 2010;125:1020–30
- Thomas RL, Parker GC, Van Overmeire B, Aranda JV. A meta-analysis of ibuprofen versus indomethacin for closure of patent ductus arteriosus. Eur J Pediatr 2005;164:135–40
- Clyman RI. Recommendations for the postnatal use of indomethacin: an analysis of four separate treatment strategies. J Pediatr 1996;128:601–7
- Redline RW, Wilson-Costello D, Hack M. Placental and other perinatal risk factors for chronic lung disease in very low birth weight infants. Pediatr Res 2002;52:713–19
- Evans N, Kluckow M. Early ductal shunting and intraventricular haemorrhage in ventilated preterm infants. Arch Dis Child Fetal Neonatal Ed 1996;75:F183–6
- Noerr B. Current controversies in the understanding of necrotizing enterocolitis Part 1. Adv Neonatal Care 2003;3:107–20
- Benitz WE. Treatment of persistent patent ductus arteriosus in preterm infants: time to accept the null hypothesis? J Perinatol 2010;30:241–52
- Sadeck LS, Leone CR, Procianoy RS, et al. Effects of therapeutic approach on the neonatal evolution of very low birth weight infants with patent ductus arteriosus. J Pediatr (Rio J) 2014. [Epub ahead of print]
- Clyman RI. Mechanisms regulating the ductus arteriosus. Biol Neonate 2006;89:330–5
- Ohlsson A, Walia R, Shah S. Ibuprofen for the treatment of a patent ductus arteriosus in preterm and/or low birth weight infants. Cochrane Database Syst Rev 2007;3:CD003481
- Van Overmeire B, Smets K, Lecoutere D, et al. A comparison of ibuprofen and indomethacin for closure of patent ductus arteriosus. N Engl J Med 2000;343:674–81
- Dang D, Wang D, Zhang C, et al. Comparison of oral paracetamol versus ibuprofen in premature infants with patent ductus arteriosus: a randomized controlled trial. PLoS One 2013;8:e77888
- Oncel MY, Yurttutan S, Erdeve O, et al. Oral paracetamol versus oral ibuprofen in the management of patent ductus arteriosus in preterm infants. A randomized controlled trial. J Pediatr 2014;164:510–14
- Lucas R, Warner TD, Vojnovic I, Mitchell JA. Cellular mechanisms of acetaminophen: role of cyclo-oxigenase. FASEB J 2005;19:635–7
- Oncel MY, Yurttutan S, Uras N, et al. An alternative drug (paracetamol) in ibuprofen resistant or contraindicated preterm infants. Arch Dis Child Fetal Neonatal Ed 2013;98:F94–5
- Yurttutan S, Oncel MY, Arayıcı S, et al. A different first-choice drug in the management of patent ductus arteriosus: oral paracetamol. J Matern Fetal Neonatal Med 2013;26:825–7
- Ozdemir OM, Dogan M, Kucuktascı K, et al. Paracetamol theraphy for patent ductus arteriosus in premature infants: a chance before surgical ligation. Pediatr Cardiol 2014;35:276–9
- Jasani B, Kabra N, Nanavati R. Oral paracetamol in treatment of closure of patent ductus arteriosus in preterm neonates. J Postgrad Med 2013;59:312–14
- Hammerman C, Bin-Nun A, Markovitch E, et al. Ductal closure with paracetamol: a surprising new approach to patent ductus arteriosus treatment. Pediatrics 2011;128:e1618–21
- Terrin G, Conte F, Scipione A, et al. Efficacy of paracetamol for the treatment of patent ductus arteriosus in preterm neaonates. Ital J Pediatr 2014;40:21–4
- Oncel MY, Yurttutan S, Degirmencioglu H, et al. Intravenous paracetamol treatment in the management of patent ductus arteriosus in extremely low birth weight infants. Neonatology 2013;103:166–9
- Tekgunduz KS, Ceviz N, Demirelli Y, et al. Intravenous paracetamol for patent ductus arteriosus in premature infants: a lover dose is also effective. Neonatology 2013;104:6–7
- Oncel MY, Yurttutan S, Erdeve O, et al. Oral paracetamol versus oral ibuprofen in the management of patent ductus arteriosus in preterm infants: a randomized controlled trial. J Pediatr 2014;164:510–14.e1
- Gokmen T, Erdeve O, Altug N, et al. Efficacy and safety of oral versus intravenous ibuprofen in very low birth weight infants with patent ductus arteriosus. J Pediatr 2011;158:549–54
- Raju NV, Bharadwaj RA, Thomas R, Konduri GG. Ibuprofen use to reduce the incidence and severity of bronchopulmonary dysplasia: a pilot study. J Perinatol 2000;20:13–16
- Sharma PK, Garg SK, Narang A. Pharmacokinetics of oral ibuprofen in premature infants. J Clin Pharmacol 2003;43:968–73
- Yang CZ, Lee J. Factors affecting successful closure of hemodynamically significant patent ductus arteriosus with indomethacin in extremely low birth weight infants. World J Pediatr 2008;4:91–6